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1. Introduction 
The Development of cryopreservation techniques, the increase in demand for cryopreserved 
cells or tissues and the use of these techniques in cells or tissues from patients with 
infectious diseases, has forced us to reduce the risk of contamination during the freezing 
process and the risk of cross-contamination during the storage of this material. Recent 
publications that demonstrate the survival of pathogens at low temperatures and possible 
contamination of the cells or tissues stored have changed the laws of each country and the 
customs and protocols used so far in the cryopreservation. 
To understand the problem of contamination in cryopreservation we need to have an 
overview of the current problem in which all researchers are concerned about, seeking a 
cryopreservation protocol with good results but without contamination problems. 
Discussing the cryopreservation’s different techniques such as slow freezing, vitrification, 
kinetic vitrification (extra-, hyper-, super-, ultra-fast vitrification) and the various 
components that help us understand the difficult balance between technique, device used 
and the risk of contamination. We need to use new products and new protocols’ to have 
good results ensuring biological samples and patient safety. 
Dr. Katkov’s idea of find the  “Universal crypreservation protocol” (see the other Chapter in the 
Book) by Katkov at al. that we can use worldwide with all the possible biological samples 
would lower considerably the price of cryopreservation process and we would have better 
results because everybody would work with the same protocol and the same results. 
We have to comprehend the difference between open, closed or semi-closed devices and the 
importance of choosing one device or another both in morphological survival post thaw cell 
or tissue as on non-contamination of these samples. The device used, the protocol used and 
the cooling solution used can change the outcome of cryopreservation and therefore we 
have to find a protocol for cryopreservation with a cooling solution and a secure device to 
provide us good results free of contamination. 
2. Contamination and cross-contamination 
The first thing we must learn is to differentiate their respective importance are the concepts 
of contamination and cross contamination of samples. The first relates to the contamination 
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of the sample by freezing or by direct contact with the cooling solution and the second refers 
to the contamination of the sample within the common container which is in contact with all 
cryopreserved samples, some samples may be contaminated or the liquid nitrogen (LN2) 
might be contaminated producing a possible cross-contamination. The potential for disease 
transmission and pathogen survival through contaminated LN2 has been proposed by 
many authors (1-3), and the evidence of contamination in human patients has been 
described for different pathogens (4-10). It has to be stated that none of the reported 
infections after insemination or ET in humans and domestic animals can be clearly 
attributed to the applied cryopreservation and storage procedure but the use of safe 
cryopreservation protocol is very important to avoid human cell contamination or cross-
contamination in common LN2 tanks. 
Although cryopreservation had a boom in the mid 70's and early 80's with the opening of 
the first sperm banks in America and Europe, it was not until the mid-80's when we saw the 
need for biological samples cryopreserved in quarantine and the lack of screening leads to 
infection of several recipients that had been inseminated with semen samples from donors 
HIV+ those unaware of their disease (11). In these cases it was found that samples stored in 
the same containers with frozen HIV+ samples were not contaminated, otherwise in 1995, 
six patients undergoing cytotoxic treatments hermetic problems developed an outbreak of 
acute hepatitis B after undergoing an autologous cryopreserved material that had been 
stored in the same cryogenic container as other patients infected with hepatitis B (12). 
2.1 Cells and tissue contamination 
In the field of assisted reproduction, although it hasn’t been detected any contamination in 
the cryopreservation of gametes and embryos, the probability and the occurrence is low, the 
risk is not zero so it is recommended to follow the rules in biosecurity manuals for both the 
physical and chemical risk as well as the risk of contamination and cross contamination of 
samples. 
The case in 1985 where there was infection with hepatitis B in the cryopreserved samples 
(12) the infection was due to an error in packaging and storage of samples. With time a 
deterioration of the bags containing infectious material causing the infection of the LN2 and 
other samples was observed. 
Further studies have shown that the storage of samples is decisive. There is evidence that 
frozen samples in hermetically sealed straws are not contaminated even if they are in 
contaminated containers with contaminated LN2 and LN2 does not contaminate infective 
biological samples that were frozen in a sealed container (13,14)  
During the cryopreservation, biological samples go through many processes before being 
cryopreserved. In the case of IVF cells are subjected to a phase of procurement, fertilization, 
development, transfer and finally cryopreservation. This represents an approximate 6-day 
process in which many factors can affect the contamination of the sample at the end of the 
process. We can find contamination or cross-contamination in the following cases (15): 
 Handling contaminated biological samples (semen, follicular fluid, tissue, etc.). Without 
precautions to avoid contamination outside the base plate to be used for conservation 
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(cryotube, straw, etc.). It is very important to disinfect and clean the container before 
filling it with LN2 (16). In this regard to ensure an adequate level of biosafety a study is 
needed of infectious diseases transmissible from any patient or donor who wants to 
freeze any samples. According to Castilla (17) the clinic policy for a donor with 
infectious diseases is radically different to that of a patient with any of these diseases 
wanting to freeze biological material for autologous use. In the first situation, the 
biological material at hand will not freeze. In the second, the biological material should 
be frozen but with measures that we discuss later. Screenings for infectious diseases 
that normally must be submitted are: To analyse serological studies for syphilis, 
hepatitis and HIV. To analyse the clinical studies infective clinical phases: 
toxoplasmosis, rubella, herpes virus, cytomegalovirus (CMV), Neisseria gonorrhoeae 
and Chlamydia trachomatis. These tests are required for donors of semen every 6 
months. As the risk of disease transmission during storage in LN2 is mainly viral. 
Interestingly, the American Society of Fertilisation (18), ESHRE (19), British Andrology 
Society (BSA) (20) and the Spanish Association of Tissue Banks (AEBT) (21) also 
recommend serologic screening for CMV, not just clinical. The presence of CMV in 
semen has been associated with active disease (anti-CMV IgM + or recent 
seroconversion anti-CMV IgG +). Similarly, these companies recommend performing 
serologic tests for HTLV-I and HTLV-II. But although it is clearly demonstrated the 
transmission of human papilloma virus by using LN2 cryotherapy and has been shown 
IUI transmission of herpes simplex virus (HSV) (22), none of the scientific associations 
mentioned above recommend a culture for detection or serological studies of HPV 
donors or patients with infection who are going to freeze biological material because 
the analysis to detect these deceases are not very sensitive. As rubella serologic 
screening of donors, its low prevalence in this population means that serological tests 
have a low positive predictive value, making it unadvisable. Finally, we believe a 
patient who needs to freeze some reproductive biological material should have at least 
one serology for HIV, hepatitis B and C. This proposal is consistent with the 
recommendations of the AEBT for cryopreservation of semen (21). 
 Use of contaminated culture media. In these cases the degree of cross-contamination 
would reach very high levels having an impact on many patients. Although the 
preparation of embryo culture media and sperm extenders from specific ingredients are 
avoided in human clinics, it continues to be a common practice in animal ART (23). 
Nevertheless, many ingredients of embryo culture media and sperm extenders act as 
stabilizers for many micro-organisms at freezing temperatures ( milk, serum or serum 
albumin, sucrose, sorbitol and other sugars). Unfortunately, the most common 
cryoprotectors (CPs) in applied oocyte cryopreservation and embryo (glycerol, DMSO, 
ethylene glycol, propylene glycol, methanol etc.) are toxic for cells. Also bacteria and 
viruses efficiently protect from cryoinjuries, eg Concentrations of DMSO as low as 5% 
enveloped viruses defend against the trauma of freezing (24). The Fact That micro-
organisms survive in association with germplasm is not only important from the 
potential of disease transmission by embryo transfer to recipients, but also in 
approaches to the storage of samples for testing and health certification of embryos for 
international movement. On the other hand we must also bear in mind that all culture 
media containing antibiotics to prevent or limit survival of microorganisms. 
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 Conservation of contaminated material or straws cryotubes closed or sealed badly 
flawed causing the breakdown of the frozen straw, leaving the contaminated sample 
directly exposed to the LN2 tank risking contaminating the other samples. Closed 
systems can be sealed in many ways (thermal sealer, ultrasound sealer, radiofrequency 
sealer, polyvinyl alcohol powders, and solid caps). Given the sealing time and the 
temperature reached does not affect the cryopreserved sample, we have to ensure that 
the seal is airtight and that the device is built of resistant material to low temperatures 
of LN2 (Ionomeric resins, quartz glass capillary, Polyvinyl chloride, Polyethylene glycol 
tetralato, etc). 
 Using contaminated LN2 during the freezing process. In this case we have proposed 
some solutions that we will see later. 
 Poor source management of LN2 from our supplier contaminating commercial LN2 that 
comes to our lab in the process of manufacture or transportation and filling our 
containers. 
 For transportation of contaminated material in containers. Storage containers should be 
emptied and cleaned periodically due to the risk of lost straws or small particles of 
contaminated material that falls to the bottom of a large container (25,26). Most of the 
companies of LN2 containers provide cleaning protocols. The main problem is the 
cleaning of transport cylinders called "dry" because the material that absorbs the LN2 in 
these bottles is difficult to sterilize. Bielanski (27) describes a method of disinfection of 
commercial dry shippers with two different types of a LN absorbent. Based on the 
results presented, it appears that solutions of sodium hypochlorite and ethylene oxide 
are equally useful for the disinfection of dry shippers constructed with a hydrophobic 
LN absorbent. In contrast, for dry shippers without a hydrophobic LN absorbent it is 
advisable to use gas only for decontamination in order sterilization to avoid their 
damage by liquid disinfectants. 
 The air in the room. If the air that reaches the lab comes from another area that could be 
contaminated and there isn’t a good filter. Some laboratories do not have filtration 
systems or positive pressure to prevent air contamination. 
 Operators. If they are infected then that can lead to contamination by contact or peeling 
during processing of samples or the handling of cryogenic tanks. Staff must meet 
certain health and hygiene conditions: negative serology for HIV, HCV, HBV and 
vaccination against hepatitis B and other viral diseases for which there is a vaccine 
available. We must also have a detailed description of their jobs, tasks and 
responsibilities. In addition the centre must provide the worker training in freezing 
techniques for updating and improving procedures. 
 Use of open devices. In recent times there is much talk of closed or open system and the 
possibility of contamination, so many countries have banned open systems and the 
trend is to ban the high risk of sample contamination. In a closed or semi-closed device 
the nitrogen of common container is never in contact with biological material frozen on 
the inside so cross-contamination cannot produced. In the open system, the biological 
material is in contact with the common nitrogen so contamination from the sample is 
very easy if the LN2 is contaminated or contamination of LN2 if the sample is 
contaminated. The latest study done by Criado and his group (28) showed 45% of 
contamination in an open device (Cryotop) Vs 0% of contamination in a semi-close 
device (Ultravit) equal and using a contaminated laboratory LN2. 
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2.2 Cooling solution contamination 
The cooling solution plays a significant role in avoiding contamination of biological 
samples. It means that we will freeze the sample and we will deposit it for a long storage 
until thawed and used. Normally the LN2 cooling solution is the most widely used in 
cryopreservation and survival of pathogens at high temperatures (-196 º C) has already been 
proven by many studies (1-3,27,28) cases also involved in seeing cross-contamination of 
human papillomavirus (14,29). 
The need for better cooling rates to avoid formation of crystals in cryopreservation has 
resulted in the discovery and use of new cooling solutions (slush, slurry, etc.). So there are 
more components to consider when contamination is to be avoided. Using these new 
cooling solutions gives a lower temperature than the LN2 temperature and much faster 
transmission. The Slush nitrogen is obtained by a vacuum pump (Telstar TOP-3; Telstar 
S.A., Terrassa, Spain) that solidifies part of the LN2 in a few minutes. On return to normal 
atmospheric pressure, the nitrogen collapses, and the subcooled LN2 has solid particles in it 
commonly referred to as ‘‘slush’’ (30).The advantage of Slush nitrogen lies not only in the 
temperature difference with respect to LN2 (-196ºC Vs -210ºC) but also in the reduction of 
the Leiden frost effect, which is the formation of a layer of vapor around the sample when 
immersed in the cryogenic liquid from room temperature decreasing the cooling rate (31,32). 
It has not yet been demonstrated the survival or non survival of pathogens in this cooling 
solution of 15-20 ° C difference in LN2, this is obtained by vacuum pressure, which can lead 
to rupture of the cell wall of pathogens to balance internal and external pressure of these in 
the process of forming Slush. The ‘Slurry’ nitrogen is a mix of LN2 with different particles 
for example copper powder. At present investigations are being carried out as an alternative 
to LN2 to increase the cooling rate because with this cooling solution the thermal conduction 
is increased. Likewise, experiments are ongoing with various solutions to increase the 
thermal conduction and the cooling rate. 
These cooling solutions "alternatives" are only used at the time of freezing the sample and 
once frozen, it passes to the general container that is filled with LN2, although these 
solutions where they freeze cool samples have to be sterile we have to ensure that the 
general LN2 container does not have contact with the frozen sample in order to not 
contaminate the sample and the LN2 if the sample is positive for any pathogen. 
Retrospective studies in which commercial LN2 cryotanks were examined after 35 
continuous years of service revealed various bacterial and fungal contaminations in the LN2 
detritus (23). Many of the identified bacteria isolated in these studies were ubiquitous 
environmental micro-organisms and were rare opportunistic pathogens of low significance 
in producing disease in humans or animals (Table I). It should be acknowledged that some 
of the isolates may have been derived from laboratory contamination during semen and 
embryo processing for cryopreservation rather than genuinely being present within the 
sample. In agreement with Bielansky and Vajta the risk of contamination by human 
pathogens seems to be rather low. Components of the standard LN2 production system 
comprise a compressor, a cryogenerator and containers. From a practical point of view, the 
complete sterilization and maintenance of sterility in such a robust system might be a very 
demanding task, if possible at all. Accordingly, some ubiquitous bacterial agents can be 
expected in any commercially produced LN2. Nevertheless, it is an ‘in and out’ system and 
only air-borne contaminants are supposed to enter it (LN2 compressor) via air used for LN2 
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production. As they are not air-borne, it is unlikely that viral agents of human concern such 
as HIV, hepatitis and herpes viruses would enter the LN2 production system.  
 
Table 1. Microbiological contamination of embryos and semen during storage in LN2 (23) 
One of the biggest discussions recently in the world of cryopreservation focuses on the 
importance of the sterility of LN2. As shown in Table I and in total agreement with 
Bielansky and Vajta and many other authors the commercial LN2 reaching our lab is not 
contaminated enough to cause any infection to freeze biological material. The major 
problem is common containers where the samples are deposited with a LN2 stored for 
months, years or even decades in contact with many samples, which, many clinics do not 
empty and do not disinfect, so it is in common containers where we can find the highest risk 
of contamination and cross contamination. 
As a possible solution to minimize the risk of freezing biological material some systems 
have been proposed where we sterilize the LN2 and where we ensure that the sample is not 
in contact with LN2 with the use of semi-close devices or devices that are the only ones that 
guarantee a hermetic sealing of the device and avoid any risk of breakage of the solder thus 
ensuring the aseptic samples. The fact that LN2 can be quickly and safely sterilized could 
encourage the clinical application of human cell/tissue vitrification, both with open carriers 
and with closed systems. The problem is that if this device is an open device and is passed 
to the general container where all the other cryopreserved samples there is a huge risk of 
cross contamination, so it has not helped. 
 LN2 Filtration: One of the solutions that have been developed is the filtration of LN2. 
Air Liquid has marketed CERALIN a liquid filtration system through LN2 ceramic 
filters. The CERALIN ON LINE consists of two elements of liquid filtration connected 
in series and inserted into a section of vacuum transfer line. The ceramic membrane is 
made from multiple layers formed into a multi-channel element. It is housed in a 
vacuum insulated pipe, itself installed close to the end-use point. The filter minimizes 
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the pressure drop and avoids the vaporization of the LN2. Thus it avoids nitrogen 
losses. Several sizes are available, depending on the nitrogen flow. The efficiency of this 
equipment was investigated and proved in laboratory. The filter is located downstream 
of the nitrogen vessel. During operation, LN2 flows through the filter and over the 
ceramic membrane. The result is high-purity LN2 with a bacteria count of less than 1 
CFU/L gas. Additionally, the large filtration area of the membrane and low level of 
contamination of LN2 means it is likely to be several decades before filter saturation. 
 
 
Fig. 1. CERALIN 
 UV Sterilization: This method is based on emitting the minimum dose on UV radiation 
necessary to kill micro-organisms that can survive at the boiling point of nitrogen (-
196°C) and which is irradiated in a temperature-controlled regimen, within a short time 
interval, before the LN2 completely evaporates. The extremely radiation-resistant 
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bacterium Deinococcus radiodurans is inactivated (>- 4log) by administe-ring 400.000 
µWs/cm² per each sterilization cycle.  An adequate amount of UV radiation de-
activates the growth of all kinds of micro-organisms, from viruses like Hepatitis (which 
require an 8.000 UV dose) to fungi like Aspergillus Niger (330.000 UV dose) (33). At 
CRYO 2011 Dr. Parmegiani spoke about a new dispositive of UV sterilization of the 
common containers with cells or tissues inside but the scientific community thinks that 
is too dangerous biological samples exposed to UV rays without any protection. 
Although his group is proposing special canisters "not transparent" I think they have to 
do many more tests to rule out damage to the samples because the common view is 
confirmed that UV light is harmful, even if used just overnight decreased embryo 
developmental rates. 
 LN2 Steam: As an alternative to hermetical storage in LN2, cryostorage contamination 
might be avoided by storing the carrier containing the vitrified oocytes in LN2 vapour 
(34, 35). However, Grout and Morris (36) maintain that storage in the vapour phase of 
LN2 still carries a risk of sample contamination. Storage of semen in LN2 vapours was 
discarded early in the development of sperm cryopreservation techniques and it was 
found that long-term viability of sperm was reduced compared with LN2 storage 
(37,38). However, recent experiments with new materials have succeeded in developing 
the technique with acceptable results for both semen and embryos (39,40) and in our 
last experiment we demonstrated 0% of contamination in vapor nitrogen in a 
experimental contaminated laboratory LN2 (non published). The drawback of the 
generalization of this form of storage is the need for careful monitoring of temperature 
in different parts of the container, which makes the marketing of these containers type 
(40) more difficult.  
 Before entering discussions regarding the sterility in LN2 used for vitrification, we 
should debate the use of communal containers, which is where cross-contamination can 
be found, as there is a possibility that the “contaminated cells” could come into contact 
with each other, and where a number of viruses and bacteria are found, which would 
never be found in the commercial LN2. 
2.3 Contamination in transport 
To carry out a safe transportation of biological material we should clearly distinguish a 
number of concepts (17). 
1. Infectious substances: those that contain viable microorganisms (bacteria, virus, prions, 
parasite, fungus) or bacterial toxins that are known or believed to cause disease in 
animals or humans. 
2. Diagnostic specimens: human or animal materials (body fluids, blood, tissue, tissue 
fluids, etc.). Obtained for diagnostic or investigational (41). 
Most often transported biological reproductive materials are cryopreserved semen donor 
and follicular fluid when the laboratory is separated from the follicular puncture site. In 
both cases, we consider the recommendations to follow are those of diagnostic specimens. 
There are several documents related to the transport of biological material, such as the 
Universal Postal Union (UPU), the International Aviation Organization (ICAO) and 
International Air Transport Association (IATA) (42-44). 
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At European level, all documents related to transport are based on the recommendations of 
the Committee of Experts of the United Nations Dangerous Goods (UN) (45). There is also a 
european agreement on international transport of dangerous goods by road (ADR), approved 
by RD 2115/9838 (46). We will describe some aspects of the mentioned regulations on the 
transport of diagnostic specimens. The basic system consists of packaging: 
1. Primary container, watertight, leak proof, labeled and contains the sample. This 
container should be wrapped in absorbent material. In terms of labeling, according to 
AEBT, if it is a semen sample from a donor, must contain an alphanumeric code that 
identifies the donor and the sample number of the donor. On the other hand, if the 
sample is for autologous use may be noted also the surname of the patient (21). 
2. Secondary container, sealed, leak-proof and protects the primary container. You can 
place multiple primary containers wrapped in a secondary container. This should be 
sufficient absorbent material used to protect all primary containers and avoid collisions 
between them. 
3. Outer shipping container: the secondary container is placed in a shipping package that 
protects the secondary container and its contents from outside elements, such as 
physical damage and water. 
The data forms, letters and other identifying information of the sample should be placed 
taped outside the secondary container. The label for submitted materials consists of: 
1. Basic triple packaging. 
2. Does not require signs from United Nations (UN). 
3. No substances require pictogram or declaration from the sender. 
4. "Biological material for clinical use" must be indicated.  
5. Tag address: 
 Name, address of destination, as detailed as possible, and phone number. 
  Name, address, telephone number and contact person at the semen bank. 
6. The documents included with the storage conditions and special instructions for 
shipping. One of the special considerations that we must have in mind when 
transporting a sample of semen is not breaking the cold chain, so you must use a 
container or LN2 as well as avoiding the possible use of dry ice. 
7. Permission for import / export and declaration. 
8. Label orientation. 
9. Date and time of departure of Semen Bank (21). 
The requirements to be met for local transport are as follows: 
1. Sealed and resistant containers. 
2. Threaded tubes upright (rack, tray ...). 
3. Use of resistant boxes and perfect closure. 
4. Secured box in the transport vehicle. 
5. Appropriate Labeling. 
6. Have the forms with necessary details. 
7. Vehicle with kit (gloves, absorbent material, disinfectant, waste container, etc.). 
You must ensure perfect coordination of transport between the sender, carrier and recipient 
to ensure delivery. Thus, each party involved should carry out its part perfectly and 
www.intechopen.com
 Current Frontiers in Cryopreservation 
 
114 
appropriately. So stand out from other actions that the sender must ensure the proper 
identification, packaging, labeling and documentation according to established biosafety 
guidelines in the "Recommendations of the Committee of Experts of the United Nations 
Transport of Dangerous Goods" transporting must be kept in appropriate conditions 
(temperature, light ...) the material from which the sender receives it until it is delivered to 
your destination and have the appropriate licenses to perform this type of transport, and 
finally, the recipient must confirm with national authorities that the material can be legally 
imported. 
According to AEBT (21), the possibility of returning a material that hasn’t been used should 
be avoided, as a rule, the return of the semen that has been provided by the Bank, as it will 
only accept the return of the displayed when you meet the following 3 conditions: 
1. The sample wasn’t thawed. 
2. You can demonstrate the integrity of the packaging (the seals are intact). 
3. The temperature of the sample was maintained throughout the transport. 
3. Open device 
Following recent studies of cell and tissue contamination in freezing and the recent debates 
regarding the sterility of LN2 in vitrification processes the devices play an important role in 
the asepsis of the frozen sample. There are many different types of device and of various 
materials but from the point of view of sterility, devices can be divided into Open, Closed 
and Semi-closed devices. 
There is a lot of controversy and confusion about the concept of Open device. For most 
cryobiologists Open devices are devices that allow direct contact of the biological sample to 
be frozen with the cooling solution but when there is contact with the interior of the device 
but not with the sample to be frozen it would not be considered an open device. Once inside 
the common cooling containers the cooling solution enters and leaves the device keeping all 
frozen samples in contact. 
 
Fig. 2. Risk of Contamination with open devices (47) 
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Generally, using open devices the achieved cooling rates are approximately 20.000-30.000 
° C / min which favor good vitrification of the sample. The problem is that being in direct 
contact with the cooling solution there is a risk of pathogen transmission to the biological 
sample at the time of freezing and a high risk of cross contamination in the common 
cooling containers. They have been prohibited in many countries for this high risk of 
contamination and the global trend is to ban them for use with human samples. Recent 
microbiological studies indicate a 45% pathogen contamination (Pseudomonas and E-coli) 
with a simple 10-second contact with the open device (Cryotop) with contaminated 
cooling solution (28). 
The most known and used open devices are the following: 
Open pulled straw 
In the OPS method, 0.25 mm standard insemination plastic mini-straws were heat-softened 
over a hot plate and pulled manually, as originally described by Vajta et al. (48). The inner 
diameter and the wall thickness of the pulled part of the straw are approximately 0.8 and 0.07 
mm respectively. Cells are load into the pulled straws by placing the narrow end of the pulled 
straw in the third droplet of medium and aspirating oocytes within a 2–3 mm long liquid 
column (1–1.5 μl) using capillarity. The straws are then cooled by being plunged directly into 
LN2 and stored briefly. For warming, the open end of the straw is immersed vertically into 4.5 
ml of the warming solution at 37°C. The solidified vitrification solution became liquid within 
1–2 s. A cooling rate of 16.700ºC/min is obtained with this device (49). 
 
Fig. 3. A) The 0.25 ml conventional straw is loaded with 1 cm of vitrification medium, 0.5 cm 
of air, 2 cm of vitrification medium containing oocytes, 0.5 cm of air, and 3.5 cm of 
vitrification medium using a syringe. (B) The open pulled straw is loaded with vitrification 
solution (1–2 μl) containing oocytes by means of the capillary effect by a simple touch. 
Cryoloop 
The Cryoloop (Hampton Research, Aliso Viejo, CA, USA ), used as a vessel in vitrification, is 
a thin nylon loop used to suspend a film of cryoprotectant containing the oocytes and 
directly immerse them in LN2. Vitrification of oocytes using the Cryoloop has advantages 
over conventional vitrification procedures in that the open system lacks a thermo insulating 
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layer, together with the small volume of <1μl, results in both rapid and uniform heat 
exchange during cooling. A cooling rate of 20000ºC/min is obtained with this device. 
 
Fig. 4. Cryoloop 
Hemi-straw 
The Hemi-straw (Astro-Med-tec, Salzburg, Austria) is an embryo carrier that consists of a 
large gutter on which a small quantity of CPAs (<1µl) containing the cell is deposited. The 
Hemi-straw is subsequently inserted into a larger pre-cooled 0.5 ml straw (CBS, Cryo Bio 
System, Grenoble, France) under LN2. Prior to the commencement of the warming process 
the Hemi-straw is pulled out of the larger straw under LN2 and the tip of the Hemi-straw is 
immediately immersed into a petri dish containing a sucrose solution. A rapid cooling rate of 
>20.000ºC/min is achieve by allowing direct contact of the biological material with LN2. (50) 
 
Fig. 5. Scheme of the Hemi-Straw: (A) loading the cell on the tip of the Hemi-Straw; (B) 
insertion of the Hemi-Straw into a larger ‘CBS’ straw. (51) 
Cryotop 
(Kitazato Supply Co, Fujinomiya, Japan) Individual oocytes were picked up in an extremely 
small volume (<0.1 μl) of vitrification  solution and placed on top of a very fine 
polypropylene strip (0.4 mm wide × 20 mm long × 0.1 mm thick) attached to a hard plastic 
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handle specially constructed according to specifications by Kitazato. The droplet volume 
was estimated from the length of the fluid column within the pipette tip. As soon as the 
oocyte was placed onto the thin polypropylene strip of the Cryotop, it was immediately 
submerged vertically into filtered LN2. Then, the thin strip was covered with a hard plastic 
cover (3 cm long) on top of the Cryotop sheet to protect it during storage in LN2 containers. 
For warming, the protective cover was removed from the Cryotop while it was still 
submerged in LN2, and the polypropylene strip of the Cryotop was immersed directly into 
the solution at 37°C for 1 min. A cooling rate of 23.000ºC/min is obtained with this device 
(49). 
 
Fig. 6. Cryotop 
Cryoleaf 
The McGill Cryoleaf™ is very similar to Cryotop but with a number of features designed to 
improve the loading and storage of cells. Safety during storage has been improved, as the 
cells are double protected from stress and contamination through a closed cover system but 
not hermetically sealed leaving cells in direct contact with LN2. The McGill Cryoleaf™ and 
the vitrification media have been developed by Dr. Chian and Prof. Tan at McGill 
University, Montreal. 
 
Fig. 7. Cryoleaf 
Cryolock 
(Biodiseño, Colombia) With this device, cells are deposited near the black mark using the 
minimal amount possible of vitrification solution (2 μl aprox.) The black mark eases the 
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cover up. The Cryolock® is immediately plunged into LN2, whilst holding the Cryolock®. 
After this the cap is grasped with forceps and plunged into LN2 until bubbling stops, be 
aware to not take the Cryolock® out of the LN2 whit covered up, twist and lock gently. 
Finally, place the Cryolock® in the goblet with the cap downward facing and store for the 
desired time. For warming, remove the patients canister form the dewar and place in a 
styrofoam box completely cover the Cryolock® with LN2. Grasp the Cryolock® body at the 
indentation with forceps and remove from the goblet. Grasp the cap at the indentation with 
forceps, twist and pull down without taking the Cryolock® body out of the LN2, it must 
always remain in LN2. Finally remove the Cryolock® from the LN2 quickly and pass into 
thawing solution at 37ºc and follow the protocol. 
 
Fig. 8. Cryolock® 
Vitri-Inga 
The Vitri-Inga vitrification strip is an apparatus that consists of a fine, very thin 
polypropylene strip (0.7 mm thick) with a specially designed round tip, in which there is a 
minute hole to receive the cell; the strip is connected to a hard and thicker plastic handle. 
Vitri-Inga´ plastic sheaths are 0.5 ml semen straws with a cut in the middle. The total time 
from when the oocyte was placed into the vitrification solution till its immersion into LN2 is 
between 50 and 60 seconds. The plastic sheaths, which had been previously cooled for at 
least 2 min in LN2 vapor on the metal rack inside in the Vitri-Equip, are vertically immersed 
into LN2. The Vitri-Inga strip with the vitrified oocyte is then inserted into the plastic 
sheaths for storage, and transferred to a LN2 tank. (52) 
 
Fig. 9. Vitri-Inga 
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Plastic-blade 
A serum Tube (Sumitomo Bakelite, Tokyo) was employed as a vessel for cryopreservation. 
A clear polyethylene terephthelate film (50 mm in thick) was cut into a T-shaped piece. As 
shown in Fig. 10, the horizontal arm of the “T” shape was rolled and fit securely to the inner 
wall of the cap. After equilibration with cryo-medium, the embryo for vitrification was 
placed at the center of a plastic blade, the vertical limb projected from the cap, and five 
embryos were the maximum allowed on one blade. The width of the plastic blade was 
significantly wider than that of the Cryotop which was commercially available tool for the 
storage of the vitrified human embryo. The blade was submerged directly into LN2 and 
inserted into the tube that was pre-cooled with LN2, then the cap was fastened on the serum 
tube, which accomplished preservation in the LN2 container. For warming, the serum tube 
that contained the plastic blade was submerged under LN2, and the serum tube was opened 
and the plastic blade containing vitrified cells was removed from the LN2 and placed 
directly into the well of the base medium at 37°C. (53) 
 
Fig. 10. Plastic-Blade 
4. Closed device 
Closed systems were born as a need to solve this direct contact with the open devices. The 
pioneer and first major proponent of close systems for freezing embryos, oocytes or sperm was 
F. Ostashko in 1960 as an aseptic alternative to the Cassou method. In such systems the 
biological sample is not in contact with the cooling solution at the time of freezing or at the 
time of storage in the common containers. This prevents contamination by contact and cross 
contamination from shared containers. The main feature is that the cooling rate is much lower 
with these closed devices. By lowering the cooling rate most vitrification protocols with closed 
systems have a high concentration of cryoprotectants to prevent crystal formation making 
them ”dangerous" protocols for the cell due to the cytotoxicity of the cryoprotective 
substances. Many comparative studies of open and closed devices listing very similar results. 
In the market there are many closed systems to vitrify and more appear daily due to the 
emphasis that cryobiologists put into to finding the perfect vitrification system that will 
prevent contamination of the sample and cross-contamination allowing a survival and cell 
viability with a protocol free or low of cryoprotective substances. The closed devices can be 
closed or sealed in many ways but most importantly a hermetic seal must be made, 
preventing entry to the inside and leakage of pathogens to the outside. Thermo seal, 
radiofrequency seal and ultrasound seal are some of the most used systems that ensure that 
the stalled sample remains suspended in time. 
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Fig. 11. Risk of Contamination with closed devices (47) 
Amongst the most commonly used closed systems are the following: 
25 to 0.5 ml Straw 
This was one of the first devices used to freeze semen, oocytes, embryos or tissues. If the 
device is not hermetically sealed they are open devices, but if they are hermetically sealed 
they are closed systems, as the sample does not come into contact with the cooling solution. 
The main problem is the cooling rate, as the device is constructed from PVC or ionomeric 
resin and having a substantional wall thickness there is little temperature transmission 
(CBS). The cooling rate achieved by these straws is approximately 2.500 ° C / min (49) 
 
Fig. 12. straw 
CVM Ring Fibre Plug 
CVM™ (Cryologic, Australia) involves the rapid cooling of specimens without their 
immersion in, or direct contact with the cooling solution. This reduces the risk of any 
potential contamination by pathogenic microorganism that may be present in the cooling 
solution. The specimens are put into a droplet which is transferred to the hook at the end of 
a custom designed fibre called a Fibreplug™.  The Fibreplug™ is then transferred to the 
specially treated surface of a CVM™ Block that has been chilled to LN2 temperature. The 
droplet vitrifies into a glassy bead and the Fibreplug™ is placed securely into a pre-cooled 
CVM™ sleeve. A cooling rate of 10.000ºC/min is obtained with this device. Besides the 
cooling rate, another main problem with this method is that to cool the CVM block the 
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surface makes contact with LN2 thus “contaminating” the surface, which could then 
provoke a contamination of the sample. 
 
Fig. 13. CVM Ring Fibre Plug 
Rapid-i™ 
Rapid-i (Vitrolife, Sweden) is based on the same principle as the open vitrification system of 
the Cryoloop meaning that the embryos are place in a minute volume of vitrification 
solution in a hole and held there by surface tension. The Rapid-i™ holding the embryos is in 
turn placed in a pre-cooled RapidStraw™ sitting in the container filled with LN2. This 
unique feature of the Rapid-i™ vitrification System means that vitrification actually takes 
place in super-cooled air reducing contamination risks. The straw is sealed after vitrification 
making the critical time frames of the dehydration steps easier to keep and creating an 
aseptic vitrification system without any contact between vitrified material and LN2. The 
main problem is that a cooling rate of 1.200ºC/min is achieved with this device (54). 
 
Fig. 14. Rapid-i 
Vitrisafe 
Is a modification of the previous Hemi-straw vitrification plug that allows a complete 
insertion in high security 0.5 ml straw. The Vitrisafe consists of a large gutter that is totally 
inserted into a larger pre-cooled 0.5 ml straw (CBS, Cryo Bio System, Grenoble, France). 
Only after welding both ends of the 0.5 ml straw to ensure the complete isolation of the 
biological sample is the complete straw plunged into LN2. For warming, the gutter is 
removed from the outer straw without contact with LN2 and the tip containing the 
biological material is directly plunged into the dilution solution in order to archive a rapid 
warming. A cooling rate of 1.300ºC/min is archived in the vitrification process (50). 
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Fig. 15. Vitrisafe 
High security vitrification straw 
The CBS™ High Security vitrification straws are made from an ionomeric resin that is 
chemically inert, biocompatible and has physical characteristics resistant to ultra low 
temperatures and pressures created by expanding liquids and LN2. Sealed straws are 
resistance tested to 150 kg/cm2 (2133 lb/sq.inch), both the seals and the material should 
resist in order to have the batch approved. The HSV (High Security Vitrification) kit is 
composed of a High Security ionomeric resin straw, a capillary tube with a pre-formed 
gutter attached to a colored handling rod and a blue plastic insertion device. For freezing 
the sample is deposited into the gutter a few millimeters from the end using a micropipette. 
The drop holding the sample must be under 0.5 µL. immediately place the capillary rod and 
handler into the straw and push until the rectangular portion of the handler comes in 
contact with the flared end of the straw. While still holding the straw in place, seal the open 
end, hold the straw using tweezers in the area of the handling rod and quickly plunge the 
entire straw into LN2 vertically. For thawing lift the straw enough to expose the colored 
handling rod. Make sure the end with the sample remains immersed in the LN2. Holding 
the straw, use the opening device for HSV kit to section the straw and immediately (within 2 
seconds), plunge the gutter into the first dilution media. A cooling rate of 2.000ºC/min is 
archived in the vitrification process (55). 
 
Fig. 16. High security vitrification straw 
CryoTip 
(Irvine Scientific) A plastic straw container which can be sealed as a closed device to hold 
gametes or embryos in a specialized medium during cryopreservation procedures and 
subsequent long term storage in a LN2 tanks. CryoTip consist of a drawn plastic straw with 
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an ultra fine tip and a protective metal cover sleeve. This device has been optimized as a 
closed system for cryopreservation procedures. For freezing aseptically remove one CryoTip 
when ready to use. Aseptically attach the wide end of the CryoTip to an aspiration tool, 
such as a luer tip syringe, using the Connector. When specimens are ready to load into the 
CryoTip, aseptically slide the metal cover sleeve carefully along the straw to expose the fine 
tip end. Gently load the specimens into the CryoTip by aspiration using the plunger on the 
syringe to control the uptake of medium and specimens. Heat seal the fine tip below the 1st 
mark, then slide the metal cover sleeve down over the fine tip to protect it and  plunge the 
sealed CryoTip into the LN2 reservoir. A cooling rate of 12.000ºC/min is obtained with this 
device (49) 
 
Fig. 17. Cryotip 
Cryopette® 
(Origio) It is derived from the original STRIPPER® family of denudation tools. It includes a 
sterile STRIPPER® tip with an integrated bulb to facilitate loading. This eliminates awkward 
external handles, rods, and pick-up tools required with other devices and guarantees 
simplicity, speed and ease of use. The bulb is designed to deliver the sample to the desired 
location every time. The maximum load volume is 1.2 µl, producing a cooling rate of 
approximately 23.700ºC/min. 
 
Fig. 18. Cryopette 
These last two devices have been criticized by Parmegiani and his group’s latest articles and 
in the last CRYO congress 2011, for the “potential danger” they have in his opinion: In the 
thawing process the external part of the device is in direct contact with the warming 
solution and any pathogen that could be on the exterior could pass onto the sample. In my 
opinion it is a very remote hypothesis and the probability that this could occur is minimal in 
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comparison with potential contamination of an open device, a bacteriological study would 
be necessary that could demonstrate that with a high % of contamination, a simple contact 
of the end of the device with the warming solution is sufficient to contaminate the sample. 
 
Fig. 19. Risk of Contamination with some closed devices (47) 
Ultravit 
Ultravit is a novel device composed of a 0.3 mm internal diameter quartz glass 
microcapillary tube and a flexible, transparent inert sheath that has been designed to protect 
and prevent it floating in the LN2. Loading the internal microcapillary tube and removing 
the cells from the device is very simple and easy using a syringe. Before warming, the 
protective sheath is cut and the internal microcapillary tube is placed in a sterile medium at 
37ºC after the thawing protocol. The open end of the sheath can be sealed ultrasonically in 
milliseconds without affecting the temperature inside the microcapillary tube, closing the 
system and ensuring a hermetic seal, thus preventing cross-contamination. The last 
microbiological control of Ultravit showed that the 5-10 seconds contact of Ultravit’s 
internal part with contaminated LN2 (E.Coli and Psudomonas) is not sufficient to produce 
direct contact of cells with the cooling solution and does not result in contamination (0% of 
Ultravit Vs 45% of Cryotop) (28).  In this study we didn’t find contamination in the 
microdrops into which we emptied the contents of the microcapillary, also submerging the 
end of this (0.2mm diameter, 0.01mm of wall thickness and 1 mm in contact with the 
warming drop). There is a great difference between thawing with an open device (in which 
the entire strip is submerged in the warming solution with a surface of 42-50 mm2) and 
thawing with Ultravit with 95.5% less of surface in contact with the warming solution at 
37ºC (1.7-1.9 mm2). With Ultravit protocol, only the end of the microcapillary touches the 
base of the dish used to thaw, but at no time does the external part touch the warming drop 
(56). The following diagram shows the use of Ultravit, presuming that the cooling solution is 
contaminated: 
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Fig. 20. Risk of Contamination with Ultravit 
Our work has demonstrated that the microorganisms that may be in the cooling solution, on 
the outside of the microcapillary, cannot come into contact with ultra-vitrified cells inside 
due to the loading procedure, the contact time with the cooling solution and the diameter 
and surface of Ultravit making it a secure device and is enough to exclude the theoretical 
danger of contamination. The cooling rate obtained with Ultravit was 250.000 Cº/min (57) 
with Slush nitrogen allowing ultra-vitrification with low concentration of CPA (1.5-2 M) and 
a morphological survival rate of 92% of human mature oocytes and 59.1% of blastulation 
rate in mouse embryos. 
5. Semi-closed device 
As a consequence of the necessity of a device which avoids contact of the biological sample 
with the cooling solution but that would achieve cooling rates high enough to ensure a high 
rate of vitrification, semi-closed devices were designed. Gabor Vajta was one of the first to 
hypothesize the enclosure of open carriers (after direct contact of cells/LN2) in pre cooled 
hermetical containers  (48). There are systems in which there is direct contact of the 
biological sample with the cooling solution only at the time of vitrification. Once the sample 
is vitrified , the device is placed in a protective sheath which is hermetically sealed before 
being passed to the communal container. This ensures no cross-contamination in the tanks. 
As stated earlier in this chapter, microbiological studies performed (23) showed that many 
of the Identified bacteria isolated  in the  commercial tanks are ubiquitous environmental 
micro-organisms and  are rare opportunistic pathogens of low significance in producing  
disease in humans or animals so these devices are an important tool for high survival of 
biological samples to avoid cross-contamination. Theoretically all open systems can become 
semi-closed systems to protect the biological sample from cross-contamination with a high 
cooling rate but the most important is:  
OPS safe method 
Vajta in 1997 devised a vitrifying system with OPS, but once submerged in LN2, the OPS 
straw is transferred to a 0.5ml CBS straw. Using this method a cooling rate of approximately 
16.700 ºC/min is achieved, but once passed into the 0.5ml CBS straw it is protected from 
cross-contamination in the common tanks. 
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A summary of the cooling rates obtained with each device is as follows: 
DEVICE VOLUME COOLING RATE 
CRYOLOOP >1 µl 20.000  ºC/min 
HEMI-SATRAW >1 µl >20.000 ºC/min 
CRYOLEAF >1 µl 23.000 ºC/min 
VITRI-INGA 1 µl 20.000 ºC/min 
CVM-RING >1 µl 10.000 ºC/min 
VITRISAFE >1 µl 1.300 ºC/min 
HSS 0.5 µl 2.000 ºC/min 
0.25 ML STRAW 25 µl 2.500 ºC/min 
OPS 1 µl 16.700 ºC/min 
CRYOTOP 0.1 µl 23.000 ºC/min 
CRYOTIP 1 µl 12.000 ºC/min 
RAPID-I 0.5 µl 1.200 ºC/min 
CRYOPETTE 1.2µl 23.700 ºC/min 
ULTRAVIT 0.2 µl 250.000 ºC/min 
Table 2. Different cooling rates 
6. Cooling rate Vs closed systems 
Today the differences between Slow freezing and Vitrification are known worldwide. We all 
know that slow freezing is characterized by a prolonged cooling curve and the use of low 
concentrations of cryo-protectors generally ‘‘non-toxic’’ for the cells (1–2 M) with cell injury 
due to ice formation (58) and that Vitrification is characterized by the rapid procedure and 
the use of a high concentration of cryo-protectors (4-6M) to prevent cell damage that is toxic 
to most mammalian cells (59-67).Thus, vitrification with a semi-close devices have a better 
cooling rate without cross-contamination or novel cyopreservation techniques are needed 
that allow rapid cooling to achieve vitrification in the absence of high concentration of CPA 
or if is possible without CPA. 
The requirements and relationships for conditions to achieve satisfactory vitrification in the 
area of mammalian ART are well displayed in the equation of Yavin and Arav (68) 
Probability of
vitrification 
Cooling and warming rates ×
Viscosity (CPA concentration)
= 
Volume
 
Fig. 21. Probability of vitrification by Yavin and Arav (68) 
The main points to be gathered from this relationship are that the smaller volume of the 
vitrification solution in which the cellular material is placed for the vitrification process, the 
faster cooling and warming rate that can be achieved and the lower concentration of CPAs 
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needed reducing the detrimental effect of the inherent toxicity of CPAs and increasing the 
overall success of the procedure (50).   
 
Fig. 22. necessary cooling rate to have a good probability of vitrification 
What would happen if We could vitrify without CPA’s or with a low concentration of 
CPA’s? What would happen if We could combine the advantages of Slow freezing and 
Vitrification and vitrify with low concentrations of CPA’s with a secure and free 
contamination device? That is Kinetic vitrification (Ultra-vitrification). Perfecting the 
techniques of Vitrification has been achieved a morphological survival rate comparable to 
normal Vitrification protocol (30) or a 59.1% of blastulation rate in mouse embryo (69) with 
Kinetic vitrification and concentrations of CPA’s typical of Slow freezing.  
Previous studies have tried to achieve high cooling rates for cell vitrification. However, none 
of them utilized low CPA concentrations (1.5-2 M). In 1985, Rall and Fahy successfully 
vitrified mouse embryos in 6.5 M cryoprotectant cocktail solution (70). In that case the 
method consisted in a 0.25 ml straw container plunged into LN2; the cooling rate was 2.500 
ºC/min. When this container was plunged into Slush nitrogen, the cooling rate increased up 
to 4000 ºC/min (71). The use of OPS (instead of the 0.25 ml straw) in LN2 increases this 
cooling rate up to 5.300 ºC/min (71) and to 10.000–20.000 ºC/min if plunged in Slush 
nitrogen (71,72). Similar cooling rates were achieved in the case of a Cryoloop quenched in 
Slush nitrogen (73). The use of electron microscope copper grids has also been investigated, 
but the cooling rates were in the same order of magnitude that the afore mentioned works: 
11.000–14.000 ºC/min in the case of plunging the grid in LN2 (74) and 24.000–30.000 ºC/min 
if plunged in Slush nitrogen (74,75). From Boutron’s theory, none of these approaches 
reaches the critical cooling rate to achieve vitrification with low concentration of CPA (1.5-
2M). It´s impossible to use open devices with Slush nitrogen as the cell is on the outside and 
there is a possibility of detaching from the device. 
Adjusting to Yavin and Arav formula the Ultra-vitrification technique arose achieving a 
cooling rate above 250.000 ºC/min and of 90.000 ºC/min in thawing. This rate is one order 
of magnitude higher than the highest cooling rate achieved in different strategies (electron 
microscope copper grids in Slush nitrogen (74,75), whilst keeping all the  advantages of a 
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straw-like form for the container and being in the range of the necessary cooling rate to 
achieve vitrification. To have this increase in the cooling rate a few changes were made to 
the normal vitrification process: 
Slush Nitrogen 
As a cooling agent this technique uses Slush nitrogen, much colder than LN2 (-196ºc Vs -
210ºC) and with the property of avoiding the Leiderfrost Effect. When something is 
submerged in LN2, bubbles rise to the surface through the device, varying the thermal 
conductivity from the outside into the inside of the device. This does not happen with Slush 
nitrogen. Slush nitrogen is achieved with a vacuum pump in 5 to 10 minutes and it remains 
slush for a further 5 – 10 minutes before returning to liquid. 
It was shown for oocytes and embryos that increasing the cooling rate would improve 
survival rates by up to 37% (76) 
 
Table 3. Effect of cooling rate on survival; comparison between LN2 and Slush nitrogen (75) 
Quartz Micro-capillary 
Another determining factor to achieve a high cooling rate is the device used. To increase the 
thermal conductivity and minimize the volume, this technique has used a quartz micro-
capillary. This has a 0.2-0.3 diameter allowing to ultra-vitrify 0.1-0.2 µl with a 0.01mm wall, 
a lot thinner than any other device (0.075 mm in OPS). Another important characteristic is 
the material it is made from: Quartz. The thermal conductivity of quartz glass is a lot higher 
than that of plastic of which other devices are made of. This converts it in one of the 
materials that best conducts the temperature (77) 
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Fig. 23. Xiaoming He et al (77) 
In a thermal performance of quartz capillaries for vitrification done by Risco and his group 
(57) a commercially available version of the OPS (MTG Medical Technological Vertriebs, 
GmbH) was used. The thermal conductivity of these PVC straws was 0.19 W m_1 K_1. The 
inner diameter is 0.800 mm and the thickness of its wall is 0.075 mm (Fig. 1a). The QC used 
(The Charles Supper Company, Inc.) have an inner diameter of 0.180 mm and a wall 
thickness of 0.010 mm. These geometrical improvements (4.44 times smaller in diameter and 
7.50 times thinner) translate not only into a faster heat transfer, but also into a 20 times 
reduction in volume of the contained solution (for a given height). This is beneficial because 
the thermal conductivity of the quartz glass is 1.3 W m_1 K_1, that is almost one order of 
magnitude higher than that of PVC. 
 
Fig. 24. (a) Thermal history for the OPS when filled with a 1.5M propane-1,2-diol and 0.3M 
sucrose cryoprotectant solution quenched in LN2 and then thawed in a water bath at 37ºC. 
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A clear heat release peak is present during cooling as well as melting during rewarming. (b) 
Thermal history for QC when filled with a 1.5M propane-1,2-diol and 0.3M sucrose 
cryoprotectant solution quenched in LN2 and then thawed in a water bath at 37ºC. 
Crystallization of water is not obvious during cooling, but melting is shown during 
rewarming. (c) Thermal history for OPS when filled with a 1.5M propane-1,2-diol and 0.3 M 
sucrose cryoprotectant solution quenched in Slush nitrogen and then thawed in a water bath 
at 37ºC. In this case, crystallization during cooling and melting during rewarming was not 
recorded. However, visual inspection reveals the presence of ice. (d) Thermal history for QC 
when filled with a 1.5Mpropane-1,2-diol and 0.3 Msucrose cryoprotectant solution 
quenched in Slush nitrogen and then thawed in a water bath at 37ºC. The sample keeps its 
transparency over all the cooling–rewarming cycle, an indication of the capability of this 
approach to vitrify the studied solution. 
All these changes have allowed us to maintain a concentration of cryoprotectors typical of 
slow freezing, 2 M PrOH+0.5 M sucrose, obtaining a morphological survival rate of 92 % in 
human oocytes (31). Dr. Ho-Joon Lee et al (69) tested this new technique on mouse ooctyes 
and they saw that using Ultra-vitrification with low concentrations of cryoprotectors 
improved the fertilization rate and above the blastulation rate. Only the use of Ultravit 
device in this technique ensures the non contamination of the sample or cross-contamination 
in communal containers. 
% 
Slow 
Freezing (78) 
Vitrification (78) 
Ultra-
vitrification 
mourine oocytes 
(69) 
Ultra-
vitrification 
human oocytes 
(31) 
Surv. rate 61 91,8 92.5 92 
Fert. rate 61,3 67,9 75 ? 
Blast. 
rate 
12 33.1 59.1 ? 
Table 4. Comparison between slow Freezing, Vitrification and Ultravitrification (78, 69, 31) 
This comparison demonstrates the use of low concentration of cryoprotectant in the Ultra-
vitrification protocol favours the morphological survival (92%) and increases the 
blastulation rate (59.1%). Thus confirming the hypothesis that cryoprotectants are toxic to 
the biological sample and if we could find a vitrification protocol that would allow us to 
vitrify without cryoprotectant, we would achieve a better embryo development and a 
greater chance of pregnancy in the case of freezing eggs or embryos. A lot more studying is 
needed regarding this new technique but a priori the results indicate that we can hopefully 
lower the concentration of the cryoprotectants decreasing the toxicity in cells. 
7. Conclusion 
Cryopreservation protocols have improved and resulted in a much higher efficiency in 
outcomes in the last years. However, it remains important to always seek for amelioration 
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on cryopreservation protocols and devices to ensure a major benefit and patients’ safety 
during procedures. We need to find a method that combines a high cooling and warming 
rate, high survival and function of cells and tissues and is made in a way that ensures 
patient safety.  
We must be clear that survival after a vitrification process is a "morphological survival" and 
that this cell has to fertilize perfectly and develop normally to rule out any damage in the 
process of cryopreservation and to consider a real survival. 
With so much variety of devices and many different protocols, laboratories have to find the 
protocol and the device that best suits their skills, provided they ensure the sterility of 
vitrified samples and prevent cross-contamination in general containers. It has created an 
exaggerated paranoia about the vitrification cell and tissue contamination of the cooling 
solution that everything can contaminate our samples. In my opinion we must think 
scientifically, leaving aside the commercial interests of many of us and worrying about more 
logical things and research data: the probability of contamination must be demonstrated 
with % of contamination and leave a little aside science fiction and theoretical assumptions. 
For many cryobiologists avoiding cross-contamination of samples in the general containers 
is the most important matter as it has been proven that commercial LN2 does not have a 
high enough risk to have to sterilize it. The use of a closed or semi-closed device that would 
allow us a high cooling rate and a sealing prior to being deposited in the general container 
should be enough to ensure sterility and good survival and development results. 
We must centre all of our interest in more practical things like finding a vitrification protocol 
that allows us to a vitrify without cryoprotectant, discovering new cooling solutions, 
discovering new materials, new devices, new procedures in which we can safely freeze 
samples without cryoprotectants toxicity problems, thus ensuring a good development cell 
after thawing, all in secure systems which ensure sterility of the sample and avoid cross-
contamination. Finding an “Universal Protocol” risen several times by Dr. Katkov (79), 
allowing us to use the same protocol worldwide, as movement of frozen specimens around 
the world has increased dramatically and the lack of component preparation in the 
laboratory that is to thaw the frozen sample with a protocol and a device different to those 
they know, would not give us 100% guarantee of sample survival. Today freezing has 
become a luxury and not all patients can afford the excessive cost of the freezing products, if 
we could find a protocol without the need of cryoprotectants or a universal protocol that all 
could use, the price of products would decrease and the patients would benefit 
economically. 
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